FI Works founder Keith Henkel says community banks and credit unions have the data, but lack a way to turn a warning sign into a call to the right person.
FI Works, which builds a relationship intelligence and engagement platform for community banks and credit unions, has launched Signals, a feature that uses machine learning to spot households likely to add a product, take up digital services or leave the
Netcall's Pol Brouckaert argues that as AI makes fake documents easier to produce, checks on whether evidence can be trusted must sit inside workflows.
Businesses have spent years automating the processing of claims, applications and supporting documents.
N26 is partnering with Franklin Templeton to launch a digital retirement account in Germany, offering ETF investments and government-backed incentives from January 2027.
N26 today announced the upcoming launch of its new private retirement account (Altersvorsorgedepot) in Germany.
India's state-backed AI Mission has funded three indigenous models, signalling a sovereign-compute strategy that rivals UPI's disruption of financial access.
India's state-backed AI Mission has funded three indigenous models, signalling a sovereign-compute strategy that rivals UPI's disruption of financial access.
A global IT firm lands a multilateral development bank as a long-term AI transformation partner, signalling institutional finance's deepening compute dependency.
A global IT firm lands a multilateral development bank as a long-term AI transformation partner, signalling institutional finance's deepening compute dependency.
Flowes launches a PayFac-as-a-Service proposition letting software platforms own the merchant payments experience without building core infrastructure.
Flowes launches a PayFac-as-a-Service proposition letting software platforms own the merchant payments experience without building core infrastructure.
Nasdaq-listed Solmate says it plans to resell UAE-sourced GPU capacity for AI training and inference, with payment options including Solana stablecoins.
The EMA's advisory committee recommended secukinumab for patients aged 12 and over with moderate to severe hidradenitis suppurativa, with an EC decision expected within